Ensysce BiosciencesENSC
13F holders, Q2 2026 (June 30)18holders +3
5new positions
2sold out
1famous investor
$0.29avg. 13F price*
At the end of Q2 2026, 18 institutions reported holding Ensysce Biosciences Inc. (ENSC) in their 13F filings, up 3 from Q1 2026. 5 opened new positions and 2 sold out. The largest holders were Jane Street Group, LLC ($61K), Adage Capital Partners Gp, L.L.C. ($43K) and Virtu Financial LLC ($28K). One famous investor held it Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Ensysce Biosciences Inc.
- CUSIP
- 293602504
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2026 → Q2 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 5 | $29K |
| Exits | 2 | $18K |
All 13F filers, Q1 2026 → Q2 2026: 462,071 shares bought and 44,337 shares sold, net +417,734 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 18 holders
| Jane Street Group, LLC | 0.00% | Add +1438.9% | 208,833 | $61K |
| Adage Capital Partners Gp, L.L.C. | 0.00% | No change | 149,711 | $43K |
| Virtu Financial LLC | 0.00% | Add +616.5% | 95,391 | $28K |
| Perceptive Advisors LLC | 0.00% | No change | 86,666 | $25K |
| Citadel Advisors | 0.00% | Add +50.3% | 86,193 | $25K |
| XTX Topco Ltd | 0.00% | Add +216.1% | 77,005 | $22K |
| Geode Capital Management, LLC | 0.00% | Reduce -15.8% | 62,188 | $18K |
| HRT Financial LP | 0.00% | New | 54,429 | $15K |
| Susquehanna International Group, LLP | 0.00% | New | 34,280 | $10K |
| Tru Independence Asset Management 2, LLC | 0.00% | No change | 13,000 | $4K |
| Two Sigma Securities, LLC | 0.00% | New | 12,953 | $4K |
| Vanguard Capital Management LLC | 0.00% | No change | 12,854 | $4K |
| Tower Research Capital LLC (TRC) | 0.00% | No change | 6,094 | $2K |
| Barclays PLC | 0.00% | New | 1,440 | $418 |
| SBI Securities Co., Ltd. | 0.00% | Add +31.9% | 641 | $186 |
| BlackRock, Inc. | 0.00% | No change | 65 | $19 |
| FNY Investment Advisers, LLC | 0.00% | No change | 3,000 | $0 |
| Clear Street Group Inc. | 0.00% | New | 1 | $0 |
"% of holder's portfolio" is ENSC's weight in each manager's 13F, not the share of Ensysce Biosciences Inc. the manager owns.